StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) KPIs and segments

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Tandem Diabetes Care's business

Tandem Diabetes Care's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Supplies and other($M)
140137150139129132128128114106118106
Pump($M)
11511014011011210212411510887.391.488.0
Net sales recognized (deferred) for Tandem Choice program($M)
000030.21.040.15-1.15-8.24
Earlier reporting (last reported 2024)1
United States($M)
179161210176170151215172157130151130
International($M)
75.386.479.973.670.583.868.172.365.261.945.955.4

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-06.

See a number that looks wrong?